SEC Comment Letter 0000000000-24-013250 to NewGenIvf Group Ltd (NIVF)
NewGenIvf Group Ltd
Date: Dec. 2, 2024 · CIK: 0001981662 · Accession: 0000000000-24-013250
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-283421
Letter
December 2, 2024 Wing Fung Alfred Siu Chief Executive Officer NewGenIvf Group Ltd 1/F, Pier 2, Central Hong Kong, 999077 Re:NewGenIvf Group Ltd Registration Statement on Form F-1 Filed November 22, 2024 File No. 333-283421 Dear Wing Fung Alfred Siu: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Nicholas O'Leary at 202-551-4451 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc:Steve Lin, Esq.
Show Raw Text
December 2, 2024
Wing Fung Alfred Siu
Chief Executive Officer
NewGenIvf Group Ltd
1/F, Pier 2, Central
Hong Kong, 999077
Re:NewGenIvf Group Ltd
Registration Statement on Form F-1
Filed November 22, 2024
File No. 333-283421
Dear Wing Fung Alfred Siu:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Nicholas O'Leary at 202-551-4451 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:Steve Lin, Esq.